Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Medical Marijuana Use in HIV+ Patients: Probability Survey (MMS)

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2014 by Wayne State University
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Mark Greenwald, PhD, Wayne State University
ClinicalTrials.gov Identifier:
NCT01536912
First received: February 16, 2012
Last updated: March 20, 2014
Last verified: March 2014
  Purpose

More scientific information is needed about medical marijuana use among HIV positive patients. There is conflicting information about the use of marijuana, use of medical marijuana, and the associations between them and health status/health risk behaviors/health care utilization. In addition, it is not clear whether patients who participate in prospective clinical studies differ from participants who do not participate; if there are differences between those two groups, then this would limit generalizability of knowledge about these issues.

The goal of this project is to describe the use of marijuana among HIV positive patients and its association with health status/health risk behaviors/health care utilization.


Condition
HIV Positive

Study Type: Observational
Study Design: Observational Model: Case-Only
Official Title: Behavioral Economic Analysis of Medical Marijuana Use in HIV+ Patients: Probability Survey

Resource links provided by NLM:


Further study details as provided by Wayne State University:

Estimated Enrollment: 300
Study Start Date: February 2012
Estimated Study Completion Date: December 2014
Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)
Detailed Description:

Participants will answer questions about marijuana, medical marijuana, and other drug use. We will also ask about health and steps participants take to keep healthy. The study will take up to one hour to complete.

Participants will also be asked to sign a release of information form. This form would allow us to look at medical records at the HIV clinic.

  Eligibility

Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

HIV positive

Criteria

Inclusion Criteria:

  • Patients in the HIV clinic
  • HIV positive

Exclusion Criteria:

  • Lack of english
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01536912

Contacts
Contact: Lisa Sulkowski, B.S. (313) 993-3966 lsulkows@med.wayne.edu

Locations
United States, Michigan
Wayne State University (HIV clinic, Tolan Park Medical Building) Recruiting
Detroit, Michigan, United States, 48201
Principal Investigator: Mark Greenwald, PhD         
Sponsors and Collaborators
Wayne State University
Investigators
Principal Investigator: Mark Greenwald, PhD Wayne State University
  More Information

No publications provided

Responsible Party: Mark Greenwald, PhD, Professor, Wayne State University
ClinicalTrials.gov Identifier: NCT01536912     History of Changes
Other Study ID Numbers: MMS-1, R01DA032678
Study First Received: February 16, 2012
Last Updated: March 20, 2014
Health Authority: United States: Federal Government
United States: Institutional Review Board

Keywords provided by Wayne State University:
HIV positive

Additional relevant MeSH terms:
HIV Seropositivity
HIV Infections
Immune System Diseases
Immunologic Deficiency Syndromes
Lentivirus Infections
RNA Virus Infections
Retroviridae Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Virus Diseases

ClinicalTrials.gov processed this record on November 20, 2014